American Italian Pasta Company

From WikiMD's WELLNESSPEDIA

American Italian Pasta Company (AIPC) was a major pasta manufacturer in the United States. Founded in 1988, the company quickly grew to become one of the largest producers of dry pasta in North America. AIPC was headquartered in Kansas City, Missouri.

History[edit]

The American Italian Pasta Company was established in 1988 by Richard Thompson and Horst W. Schroeder. The company aimed to produce high-quality pasta products for the American market. AIPC's first manufacturing plant was located in Excelsior Springs, Missouri. Over the years, the company expanded its operations by opening additional plants in Columbia, South Carolina, Tolleson, Arizona, and Verolanuova, Italy.

Products[edit]

AIPC specialized in producing a wide range of dry pasta products, including spaghetti, fettuccine, penne, and macaroni. The company supplied pasta to both retail and foodservice markets under various brand names, including Pasta LaBella, Golden Grain, and Heartland.

Acquisition[edit]

In 2010, AIPC was acquired by Ralcorp Holdings, a major manufacturer of private-label food products. The acquisition allowed Ralcorp to expand its product offerings and strengthen its position in the pasta market. Following the acquisition, AIPC continued to operate under the Ralcorp umbrella until Ralcorp itself was acquired by ConAgra Foods in 2013.

Manufacturing Facilities[edit]

AIPC operated several state-of-the-art manufacturing facilities equipped with advanced technology to ensure the production of high-quality pasta. The company's plants were strategically located to optimize distribution and reduce transportation costs.

Corporate Social Responsibility[edit]

AIPC was committed to sustainable practices and corporate social responsibility. The company implemented various initiatives to reduce its environmental impact, including energy-efficient manufacturing processes and waste reduction programs.

See Also[edit]

References[edit]


External Links[edit]


Sponsored Health Resource

W8MD weight loss success

W8MD Weight Loss, Sleep & MedSpa

Looking for physician-supervised weight loss, semaglutide, tirzepatide, or GLP-1 receptor agonist options? W8MD helps eligible patients in New York City, Brooklyn, New Jersey, Connecticut, Pennsylvania, Delaware, and greater Philadelphia with medical weight loss, sleep medicine, and long-term maintenance support.

GLP-1 specials: Affordable GLP-1 injections NYC and Philadelphia starting from $29.99/week and up for semaglutide with insurance accepted for qualifying visits, and $45/week and up for tirzepatide with insurance accepted for qualifying visits. Self-pay options start from $59.99/week and up for semaglutide and $69.99/week and up for tirzepatide.

Medical weight loss NYC | Affordable GLP-1 injections NYC | Budget GLP-1 weight loss shots Philadelphia | New Jersey medical weight loss | NYC medical weight loss | Philadelphia medical weight loss | Sleep clinic NYC | W8MD's Philadelphia GLP-1 doctor | Weight loss prescriptions NYC

Book a W8MD appointment · View GLP-1 specials

Paid promotional message. Eligibility, pricing, insurance coverage, medication availability, and results vary. Medical evaluation required.

Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.

Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.